STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma.
Najem H, Lea ST, Tripathi S, Hurley L, Chen CH, William I, Sooreshjani M, Bowie M, Hartley G, Dussold C, Pacheco S, Dmello C, Lee-Chang C, McCortney K, Steffens A, Walshon J, Ott M, Wei J, Marisetty A, Balyasnikova I, Stupp R, Lukas RV, Hu J, James CD, Horbinski CM, Lesniak MS, Ashley DM, Priebe W, Platanias LC, Curran MA, Heimberger AB.
Najem H, et al. Among authors: sooreshjani m.
J Clin Invest. 2024 Jun 17;134(12):e175033. doi: 10.1172/JCI175033.
J Clin Invest. 2024.
PMID: 38941297
Free PMC article.